Device developer and manufacturer Phillips-Medisize has acquired Danish device company Medicom Innovation Partner (formerly Bang & Olufsen Medicom) for an undisclosed amount. The company said that, “The addition of Medicom’s capabilities expands Phillips-Medisize’s end-to-end injectable and inhalation device innovation service solutions for biopharma customers, including early device strategy, human factors engineering, product development, clinical production, full scale production and integrated supply chain management.”
Phillips-Medisize Chairman, CEO and President Matt Jennings commented, “This transaction is consistent with our strategic focus on serving the rapidly growing diabetes, biologics, specialty pharmaceutical and personalized oncology markets that need these products and reinforces our leading position in drug delivery device solutions. Medicom’s impressive solutions, 25 years of expertise and 100+ state-of-the-art technology accelerators, coupled with Phillips-Medisize’s scale in design to manufacturing of high to low volume production drug delivery devices, will provide customers with end-to-end integrated service solutions, resulting in increased speed to market. We are excited to welcome the talented Medicom team to Phillips-Medisize and look forward to working together to deliver services and solutions that improve patient compliance and outcomes.”
Medicom CEO Morten Nielsen said, “We are pleased to partner with Phillips-Medisize, a recognized global leader with an impressive track record of delivering a broad and deep set of capabilities to customers. We are confident that customers of both companies will benefit from an enhanced offering of end-to-end integrated service solutions across a global network while continuing to receive the same best-in-class service that they have come to expect. Importantly, our companies are culturally aligned and we share the same deeprooted passion for innovation which improves our customers’ competitiveness.
Phillips-Medisize was acquired by Golden State Capital in 2014.
Read the Phillips-Medisize press release.
